Profile of Nasopharyngeal Cancer Patients who Underwent Radiotherapy in Dr. Hasan Sadikin General Hospital Bandung

Indira Meidina Nafisa, Marhendra Satria Utama, Mas Adi Sunardi, Antony Abel Adibrata

Abstract


Background: Nasopharyngeal cancer (NPC) is a malignant epithelial tumor located in the nasopharynx and is the most common head and neck malignancy. This study aimed to find and describe the profile of NPC patients who undergo radiotherapy at Dr. Hasan Sadikin General Hospital, Bandung.

Methods: This study was a descriptive study conducted at the Department of Radiology of Dr. Hasan Sadikin General Hospital, Bandung. This study employed a total sampling method and was done by observing patients’ status/medical records from January 1, 2018, to December 31, 2019, which was registered based on the Hospital-Based Cancer Registry (HBCR). The inclusion criteria were all patients diagnosed with NPC and undergone radiotherapy.

Results: There were 274 records (19.74%) included as NPC from 1,388 records. This cancer was more frequent in men (70.4%), in the age group of 45–54 years (35.0%), non-active smokers (58.8%), entrepreneurs (23.0%), and those who came from West Priangan (36.1%). The most common chief complaint was an enlargement of neck lymph nodes (55.1%) at stage IVB (42.8%). Histopathological findings were dominated by undifferentiated squamous cell carcinoma (WHO III) (74.4%). Most of the patients were treated with chemoradiation (64.3%).

Conclusions: NPC could happen to anyone with different background. This study found it was more frequent in men than women (2.3:1), in the fourth and fifth decade of life, in entrepreneurs followed by housewives, and even in non-active smokers. It also could happen in children to the elderly. Most patients came with an enlargement of neck lymph nodes as their chief complaint in the advanced stage and need chemoradiation as their treatment.


Keywords


cancer profile, cancer registry, nasopharyngeal cancer, radiotherapy

References


Salehiniya H, Mohammadian M, Mohammadian-Hafshejani A, Mahdavifar N. Nasopharyngeal cancer in the world: epidemiology, incidence, mortality and risk factors. World cancer Res J. 2018;5(1).

Wu L, Li C, Pan L. Nasopharyngeal carcinoma: A review of current updates. Exp Ther Med. 2018;15(4):3687–92.

World Health Organization. Indonesia Source GLOBOCAN 2018. Int Agency Res Cancer [Internet]. 2019;256:1–2. Available from: http://gco.iarc.fr/

Washington CM, Leaver D. Principles and Practice of Radiation Therapy. 4th ed. Vol. 15, Radiography. Elsevier Ltd; 2017. 357 p.

Adham M, Gondhowiardjo S, Soediro R, Al E. Pedoman Nasional Pelayanan Kedokteran Kanker Nasofaring. Jakarta, Indonesia: Kementerian Kesehatan Republik Indonesia; 2017.

Pfister DG, Spencer S, Adelstein D, et al. Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2020 Jul;18(7):873–98.

Lu JJ, Cooper JS, Lee AWM. Nasopharyngeal cancer: multidisciplinary management. Springer Science & Business Media; 2010.

Amin MB, Greene FL, Edge SB, et al. AJCC Cancer Staging Manual. eight. Chicago: Springer International Publishing; 2017.

Dinas Kesehatan Provinsi Jawa Barat. Profil Kesehatan di Jawa Barat Tahun 2016. Dinas Kesehatan Jawa Barat. Bandung; 2017.

Diniati A, Fidiawati WA, Harianto H. Distribusi Keganasan Nasofaring Berdasarkan Pemeriksaan Histopatologi pada Rumah Sakit di Kota Pekanbaru Tahun 2009-2013. Riau University; 2016.

Adham M, Kurniawan AN, Muhtadi AI, et al. Nasopharyngeal carcinoma in Indonesia: epidemiology, incidence, signs, and symptoms at presentation. Chin J Cancer. 2012;31(4):185.

Jayalie VF, Paramitha MS, Jessica J, et al. Profile of Nasopharyngeal Carcinoma in Dr. Cipto Mangunkusumo National Hospital, 2010. eJournal Kedokt Indones. 2017;156–62.

González-Motta A, González G, Bermudéz Y, et al. Pediatric nasopharyngeal cancer: case report and review of the literature. Cureus. 2016;8(2).

Cempako G, Windiastuti E. Karsinoma Nasofaring pada Anak: Karakteristik, Tata Laksana dan Prognosis. Sari Pediatr. 2016;13(1):79–84.

Long M, Fu Z, Li P, Nie Z. Cigarette smoking and the risk of nasopharyngeal carcinoma: a meta-analysis of epidemiological studies. BMJ Open. 2017;7(10):e016582.

Chang ET, Liu Z, Hildesheim A, et al. Active and passive smoking and risk of nasopharyngeal carcinoma: a population-based case-control study in southern China. Am J Epidemiol. 2017;185(12):1272–80.

Hsu W, Chien Y, Huang Y, et al. Cigarette smoking increases the risk of nasopharyngeal carcinoma through the elevated level of IgA antibody against Epstein‐Barr virus capsid antigen: A mediation analysis. Cancer Med. 2020;9(5):1867–76.

Al-Azri A, Al-Sheibani S. Nasopharyngeal Carcinoma in Oman: A descriptive analysis. Oman Med J. 2015;30(3):167.

Azizah N, Hanriko R, Ramkita N. Hubungan antara Konsumsi Ikan Asin, Ikan/Daging Asap, dan Makanan Berkaleng dengan Karsinoma Nasofaring di RSUD Abdul Moeloek Periode Tahun 2014-2016. J Agromedicine. 2018;4(2):260–3.

Christanti J, Prasetyo A. Tingkat Ketahanan Hidup Penderita Kanker Nasofaring pada Berbagai Modalitas Terapi Studi Kasus yang Menjalani Terapi Konvensional dan Pengobatan Komplementer Alternatif. Media Med Indones. 2012;46(2):138–48.

Waliyanti E, Dewi FST, Supriyati S, Fles R. Treatment-seeking behaviour of nasopharyngeal cancer patients in Yogyakarta, Indonesia. Pan Afr Med J. 2018;29(1):1–6.

Suta PD, Saputra KA, Sutanegara SW. Profil Penderita Kanker Nasofaring di Rumah Sakit Umum Pusat Sanglah Denpasar Periode Januari-Desember tahun 2014. EJ Med. 2014;8:1395–408.

Antono D, Muyassaroh RS, Sari RP. Cranial nerve disorders in nasopharyngeal carcinoma cases at Dr. Kariadi General Hospital Semarang-Indonesia, 2014-2016. Age (Omaha). 2014;2015:2016.

Faiza S, Rahman S, Asri A. Karakteristik klinis dan patologis karsinoma nasofaring di bagian THT-KL RSUP Dr. M. Djamil Padang. J Kesehat Andalas. 2016;5(1).

Beyzadeoglu M, Ozyigit G, Ebruli C. Basic Radiation Oncology. Vol. 53, Journal of Chemical Information and Modeling. London: Springer; 2010. 1689–1699 p.

Sekarutami SM, Gondhowiardjo S, Yuliasti R, et al. Survival of nasopharyngeal cancer in national referral hospital of Indonesia: A study on radiotherapy patients. Oral Oncol. 2020;106:104707.

Dawolo AP, Utama DS, Kasim BI. Profil Klinis Karsinoma Nasofaring di Departemen THTKL RSUP Dr. Mohammad Hoesin Palembang Tahun 2014-2015. Maj Kedokt Sriwij. 2017;49(1):1–9.

Wildeman MA, Fles R, Herdini C, et al. Primary treatment results of nasopharyngeal carcinoma (NPC) in Yogyakarta, Indonesia. PLoS One. 2013;8(5):e63706.

Grover S, Xu MJ, Yeager A, et al. A systematic review of radiotherapy capacity in low- and middle-income countries. Front Oncol. 2014;4:380.

Yap ML, Zubizarreta E, Bray F, et al. Global Access to Radiotherapy Services: Have We Made Progress During the Past Decade? J Glob Oncol. 2016 Aug;2(4):207–15.

Brennan MF, Antonescu CR, Maki RG. Management of soft tissue Sarcoma. second. Vol. 9781461450, Management of Soft Tissue Sarcoma. Switzerland: Springer; 2016. 1–380 p.

Frenkel M. Refusing Treatment. Oncologist. 2013;18(5):634–6.

Hansen H, Skovhus Thomsen M. EP-1851: Why is planned palliative radiotherapy often cancelled? A retrospective exploratory study. Radiother Oncol [Internet]. 2017;123:S1012. Available from:

http://dx.doi.org/10.1016/S0167-8140(17)32286-7

Chen W, Hu G-H. Biomarkers for enhancing the radiosensitivity of nasopharyngeal carcinoma. Cancer Biol Med. 2015;12(1):23.


Full Text: PDF

DOI: 10.33371/ijoc.v16i2.869

Article Metrics

Abstract view : 200 times
PDF - 111 times

Refbacks

  • There are currently no refbacks.


Copyright (c) 2022 Indonesian Journal of Cancer

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.